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PH-domain containing protein 
A B S T R A C T   
Plasmodium, the causative agents of malaria, are obligate intracellular organisms. In humans, pathogenesis is 
caused by the blood stage parasite, which multiplies within erythrocytes, thus erythrocyte invasion is an essential 
developmental step. Merozoite form parasites released into the blood stream coordinately secrets a panel of 
proteins from the microneme secretory organelles for gliding motility, establishment of a tight junction with a 
target naive erythrocyte, and subsequent internalization. A protein identified in Toxoplasma gondii facilitates 
microneme fusion with the plasma membrane for exocytosis; namely, acylated pleckstrin homology domain- 
containing protein (APH). To obtain insight into the differential microneme discharge by malaria parasites, in 
this study we analyzed the consequences of APH deletion in the rodent malaria model, Plasmodium yoelii, using a 
DiCre-based inducible knockout method. We found that APH deletion resulted in a reduction in parasite asexual 
growth and erythrocyte invasion, with some parasites retaining the ability to invade and grow without APH. APH 
deletion impaired the secretion of microneme proteins, MTRAP and AMA1, and upon contact with erythrocytes 
the secretion of MTRAP, but not AMA1, was observed. APH-deleted merozoites were able to attach to and deform 
erythrocytes, consistent with the observed MTRAP secretion. Tight junctions were formed, but echinocytosis 
after merozoite internalization into erythrocytes was significantly reduced, consistent with the observed absence 
of AMA1 secretion. Together with our observation that APH largely colocalized with MTRAP, but less with 
AMA1, we propose that APH is directly involved in MTRAP secretion; whereas any role of APH in AMA1 
secretion is indirect in Plasmodium.   
1. Introduction 
Plasmodium protozoan parasites are the causative agents of malaria, 
a life-threatening disease with 229 million malaria cases and 409,000 
deaths in 2019 [1]. Plasmodium spp. belong to the phylum Apicomplexa, 
whose members are largely obligate intracellular parasites. For human 
malaria, clinical manifestation of infection and pathogenesis is due to 
asexual stage proliferation within erythrocytes; and erythrocyte 
invasion is an essential step for Plasmodium blood stage development. 
This process consists of several specific molecular interactions between 
the merozoite form parasite and the host erythrocyte [2–4]. After initial 
attachment of the merozoite to the erythrocyte, the merozoite reorients 
and deforms the erythrocyte to establish an irreversible tight junction 
between the parasite anterior end and the erythrocyte membrane. 
During these steps, one or more thrombospondin-related anonymous 
protein (TRAP) family proteins are likely responsible for the erythrocyte 
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deformation, mediated through merozoite gliding motility [5]. Addi-
tionally, reticulocyte-binding-like (RBL or Rh) proteins were proposed 
to be involved in the target cell selection [6], and erythrocyte-binding- 
like (EBL) proteins are responsible for the tight junction formation [7,8]. 
The merozoite actively internalizes into an erythrocyte, mediated by the 
parasite actomyosin motor machinery using a scaffold structure between 
the merozoite and the erythrocyte membrane, called a moving junction. 
The moving junction is formed by an interaction between apical mem-
brane antigen 1 (AMA1) on the merozoite surface and rhoptry neck 
protein (RON) complex proteins that are inserted to the erythrocyte 
membrane - a model in part based on observations in T. gondii [9,10]. 
The posterior movement of this junction drives merozoite entry into the 
nascently formed parasitophorous vacuole in the erythrocyte [11]. The 
invaded erythrocyte undergoes echinocytosis, a minutes long deforma-
tion of the erythrocyte with the appearance of transient spike-like ex-
trusions of the surface membrane [12,13]. 
Secretion of microneme proteins, such as TRAP, EBL, and AMA1, are 
regulated by a sequence of signaling events involving kinases, lipids, and 
calcium [14]. According to a model largely generated by characteriza-
tion of T. gondii MIC2 (a homolog of Plasmodium TRAP proteins) and 
AMA1, diacylglycerol is produced during a signaling cascade involving 
phospholipase C. The diacylglycerol is further converted to phosphatidic 
acid (PA) by a diacylglycerol kinase on the inner leaflet of the plasma 
membrane, which is then recognized by acylated pleckstrin homology 
(pH) domain-containing protein (APH) on the cytosolic face of the 
microneme membrane. The binding of APH to PA facilitates juxtaposi-
tion of these two membranes, to release the contents of micronemes 
[15,16]. A double C2 domain protein, DOC2.1, was reported to be 
responsible for microneme membrane fusion in T. gondii and Plasmodium 
falciparum [17]. Compared to TRAP/MIC2 and AMA1, for which ho-
mologs are found among all apicomplexan parasites, RBL and EBL are 
only found in Plasmodium spp. In P. falciparum, RH1, an RBL family 
member, is required for the secretion of EBA175, an EBL family member 
[18]. A pleckstrin homology domain-containing protein, PH2, was 
proposed to be involved in EBA175 secretion, and this protein showed 
higher binding activities to phosphoinositides than PA and is not 
involved in AMA1 secretion [19]. Thus, two signaling cascades appear 
to control the exocytosis of microneme vesicles. 
T. gondii APH (TgAPH) colocalizes with the microneme proteins 
MIC2, MIC4, and MIC6, and its trafficking is regulated via N-terminal 
palmitoylation and myristoylation [20]. Conditional knockdown of 
TgAPH resulted in pronounced defects in both parasite egress and in-
vasion. TgAPH-knockdown parasites also exhibited a defect in secretion 
of MIC2 and another microneme protein, AMA1, but did not alter 
microneme biogenesis, localization, and intracellular growth. Specific 
interaction with PA was shown for recombinant TgAPH as well as re-
combinant P. falciparum APH. Because APH is conserved across Api-
complexa, a similar role is expected for malaria parasites [20]. However, 
the erythrocyte invasive merozoite stage of malaria parasites has unique 
features absent in T. gondii; for example, only Plasmodium merozoites 
possess EBL and RBL protein families, and Plasmodium egress is not 
controlled by microneme proteins [21]. 
Rodent malaria parasite models offer ease in laboratory maintenance 
and experimental genetic modifications. In the previous study, we re-
ported Plasmodium yoelii required several minutes after egress for mer-
ozoites to invade erythrocytes [2]. Based on this unique feature, we 
developed methods to purify P. yoelii merozoites retaining competency 
to invade erythrocytes for more than 4 h [22] and to capture a large 
number of erythrocyte invasion events by video time-lapse video im-
aging for 40 min [8]. Utilizing these research resources, in this study, we 
investigated the roles of APH in malaria parasites by analyzing trans-
genic P. yoelii 17×L lines in which the aph gene locus (PY17×_0716800) 
was conditionally excised using the dimerisable Cre-recombinase 
(DiCre)-loxP system [23]. 
2. Materials and methods 
2.1. Parasites and animals 
DiCre-expressing P. yoelii 17XL (17X-DiCre) and PyPKAc-iKO para-
sites were generated previously [23]. P. yoelii parasites were maintained 
through inoculation of 6–8-week-old ICR or BALB/c female mice (Japan 
SLC, Hamamatsu, Japan). All animal studies were performed under the 
approval of the Animal Care and Use Committee of Nagasaki University. 
2.2. Plasmid construction 
To construct the pDC2-Cas9-PyU6-PyAPH-3’loxP-hDHFR/yFCU 
plasmid, the pDC2-cam-Cas9-PyU6-hDHFR plasmid [23] was digested 
with BbsI and ligated with a DNA fragment containing a gRNA1 
component targeting the P. yoelii aph gene locus (PY17X_0716800). The 
aph gene locus was amplified from P. yoelii 17XL genomic DNA (gDNA) 
with primers P18 and P19 using an In-Fusion HD cloning kit (Takara Bio 
Inc., Shiga, Japan). Then, a DNA fragment containing a sequence 
encoding the 5′ homologous region (HR1) of the aph gene locus followed 
by Myc epitopes and a DNA fragment containing a loxP sequence and 3’ 
HR (HR2) of the aph gene locus were PCR-amplified from P. yoelii 17XL 
gDNA using primers P20 and P21 or P24 and P25, respectively, then 
ligated using the In-Fusion method with the above plasmid digested with 
HpaI and AatII. The generated plasmid was digested with NotI and 
ligated using the In-Fusion method with a DNA fragment containing an 
hDHFR/yFCU expression cassette amplified from the pDC2-Cas9-PyU6- 
PypPK1-Myc [24] plasmid with P22 and P23. Parasite gDNA was 
extracted using a QIAamp DNA blood mini kit (Qiagen, Hilden, 
Germany). 
To construct the pDC2-Cas9-PyU6-PyAPH-5’loxPi plasmid, pDC2- 
cam-Cas9-PyU6-hDHFR plasmid was digested with BbsI and ligated 
with a DNA fragment containing the gRNA2 component targeting the 
aph gene locus and amplified from P. yoelii 17XL gDNA with primers P26 
and P27 using an In-Fusion HD cloning kit. Then, HR3 and HR4 were 
amplified from parasite gDNA with primers P28 and P29 or P30 and 
P31, respectively. LoxP-intron sequence (103 bp) and a NotI site were 
added to primers P30 and P31, respectively, for HR4 [25]. The gRNA2- 
inserted plasmid was digested with HpaI and AatII and the HR3 and HR4 
fragments were inserted using the In-Fusion method. The resulting 
plasmid was digested with NotI and a DNA fragment containing hDHFR/ 
yFCU expression cassette amplified with P32 and P33 was then inserted 
as described. 
To construct the pDC2-Cas9-PyU6-PyMTRAP-Ty plasmid, the pDC2- 
cam-Cas9-PyU6-hDHFR plasmid was digested with BbsI and ligated with 
a DNA fragment containing the gRNA3 component targeting the mtrap 
gene locus. The mtrap gene locus was amplified from P. yoelii 17XL gDNA 
with primers P34 and P35 using an In-Fusion HD cloning kit. Then, the 
HR5 with a sequence coding for a Ty epitope and HR6 were amplified 
from parasite gDNA with primers P36 and P37 or P40 and P41, 
respectively. The gRNA3-inserted plasmid was digested with HpaI and 
AatII and these two DNA fragments were inserted using the In-Fusion 
method. A DNA fragment containing an hDHFR/yFCU expression 
cassette was amplified with P38 and P39 and ligated with the above 
NotI-digested plasmid. All primers used to generate plasmids are shown 
in the supplemental Table S1. The plasmids for transfection were pre-
pared using a HiSpeed Plasmid Midi Kit (Qiagen, Hilden, Germany). 
2.3. Generation of transgenic parasite lines 
Firstly, the 3′ side of the aph gene locus of a P. yoelii 17XL-based 
parasite cloned line expressing DiCre recombinase [23] was modified 
using the CRISPR/Cas9 genome editing method using the plasmid pDC2- 
Cas9-PyU6-PyAPH-3’loxP-hDHFR/yFCU to yield two APH-3’loxP pre- 
5FC parasite lines. To remove the hDHFR/yFCU expression cassette 
from the parasite genome, negative selection was done by oral 
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administration of 5-fluorocytosine (5FC; Sigma-Aldrich, St. Louis, Mis-
souri, USA) via drinking water (1 mg/mL) to yield 2 APH-3’loxP parasite 
lines [26]. After cloning, the 5′ side of the aph gene locus of two APH- 
3’loxP cloned parasite lines was further modified using a plasmid pDC2- 
Cas9-PyU6-PyAPH-5’loxPi, the hDHFR/yFCU expression cassette was 
removed as above, and then cloning was performed to yield PyAPH-iKO 
clones #1 and #2. PyAPH-iKO clone #1 was further modified to tag its 
PyMTRAP with a Ty epitope using the plasmid pDC2-Cas9-PyU6-PyM-
TRAP-Ty. 
Transfection to P. yoelii was performed as described with minor 
modifications [8]. Schizonts were enriched by density gradient centri-
fugation using Nycodenz solution (1.077 g/mL) and were mixed with 
human T cell nucleofector solution (Lonza, Basel, Switzerland) con-
taining 20 μg of circular plasmids and electroporated using a Nucleo-
fector™ 2b device (Lonza; U-33 program). Drinking water containing 
0.07 g/mL pyrimethamine (Fukuzyu Pharmaceutical Co., LTD, Toyama, 
Japan) was administrated orally beginning 1 day post transfection and 
parasites emerged following drug selection were passaged to a new 
mouse, then cloned by limiting dilution. To confirm the modification of 
the target gene locus, gDNA of transfectants were extracted using a 
QIAamp DNA Blood Mini Kit (Qiagen), and PCR with specific diagnostic 
primer pairs (Table S1) and Southern blot analysis were performed. 
2.4. Southern blotting 
Ten micrograms of parasite gDNA was digested with HpaI and EcoRI 
for probe 1 amplified with primers P10 and P11 from parasite gDNA or 
NdeI and ScaI for probe 2 amplified with primers P12 and P13 using 
plasmid as template (Fig. 1). The pDC2-Cas9-PyU6-PyAPH-5’loxPi 
plasmid digested with Apal and KpnI was used as a control. Digested 
DNA was loaded onto an agarose gel for electrophoresis and transferred 
to HyBond N+ membrane (GE Healthcare, Buckinghamshire, U.K.). 
Probes were labeled and hybridized using an AlkPhos Direct kit (GE 
Healthcare) and chemiluminescent signals from CDP-star (GE Health-
care) was detected by a multipurpose charge-coupled-device (CCD) 
camera system (LAS-4000 mini; Fujifilm, Tokyo, Japan) with Multi 
Gauge software (Fujifilm). 
Fig. 1. Generation of PyAPH-iKO parasite lines. 
(A) Schematic of the pDC2-Cas9-PyU6-PyAPH-3’loxP-hDHFR/yFCU plasmid and the original (P. yoelii 17XL DiCre aph locus) and modified aph gene locus (APH- 
3’loxP pre-5FC and APH-3’loxP). (B) Schematic of the pDC2-Cas9-PyU6-PyAPH-5’loxPi plasmid and the modified aph gene locus (APH-3’loxP, APH-iKO, and APH- 
iKO + RAP). 3′U, 3′ untranslated region; 5′U, 5′ untranslated region; CAM, calmodulin; DT, dihydrofolate reductase-thymidylate synthase; EF1α, elongation factor 1 
alpha; hDHFR, human dihydrofolate reductase; HR, homologous region; HSP86, heat shock protein 86; i, intron; Pb, P. berghei; Pf, P. falciparum; Py, P. yoelii; U6, U6 
small nuclear RNA; yFCU, yeast cytosine deaminase and uridyl phosphoribosyl transferase. Sites cleaved by restriction enzymes, HpaI, ScaI, NdeI, and EcoRI, and sites 
where oligonucleotide primers and Southern blot probes were designed are shown with the expected sizes by PCR or Southern blot analysis. (C) Genotyping PCR to 
evaluate the modification of the aph gene locus of 17XL DiCre parasite and APH-3’loxP parasites before and after 5FC treatment. For the PyAPH-3’loxP parasite, only 
clone #1 is shown. (D) Genotyping PCR to evaluate the modification of the aph gene locus of APH-3’loxP and APH-iKO parasites before and after RAP treatment. (E) 
Southern blot analysis for DNA fragments digested with HpaI and EcoRI and detected with probe 1. (F) Southern blot analysis for DNA fragments digested with NdeI 
and ScaI and detected with probe 2. The pDC2-Cas9-PyU6-PyAPH-5’loxPi plasmid digested with ApaI and KpnI was used as a positive control. 
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2.5. Indirect immunofluorescence assay (IFA) 
Blood smears were fixed with 4% paraformaldehyde and 0.075% 
glutaraldehyde (PFA-GA) in phosphate-buffered saline (PBS) at room 
temperature (RT) for 15 min. Smears were incubated with 0.1% Triton 
X-100 in PBS at RT for 10 min for permeabilization, washed twice with 
PBS at RT for 5 min, and further incubated with 3% BSA in PBS at RT for 
1 h for blocking. Subsequently, smears were incubated with primary 
antibodies at RT for 1 h then further incubated with secondary anti-
bodies with 4′, 6-diamidino-2-phenylindole (DAPI; Invitrogen) at RT for 
30 min. Primary antibodies were rabbit anti-Myc monoclonal antibody 
(1:500; 71D10; Cell Signaling Technology, Danvers, MA, USA), mouse 
anti-Myc monoclonal antibody (1:500; 9B11; Cell Signaling Technol-
ogy), mouse anti-Ty monoclonal antibody (1:500; Diagenode, Liege, 
Belgium), rabbit anti-PyAMA1 (1:250) [27], rabbit anti-PyEBL (1:250) 
[28], rabbit anti-PyRON5 antibody (1:250) [27], mouse anti-Py235 
antibody (1:250; mAb25.86; a kind gift from A. Holder) [29], or 
mouse anti-PbHSP70 monoclonal antibody (1:20; a kind gift from J. 
Sattabongkot). Secondary antibodies were Alexa fluor 488-conjugated 
goat anti-mouse IgG, Alexa fluor 488-conjugated goat anti-rabbit IgG, 
Alexa fluor 594-conjugated goat anti-rabbit IgG, or Alexa fluor 594-con-
jugated goat anti-mouse IgG. IFA smears were washed with PBS, briefly 
air-dried, and mounted with VECTASHIELD antifade medium (Vector 
laboratories, Burlingame, CA, USA). Images were acquired with a 
confocal microscope (Nikon A1R; Nikon, Japan). Pearson's correlation 
coefficient was calculated by imageJ (v1.53) and JaCoP plugin (v2.1.4). 
2.6. Rapamycin (RAP) treatment, parasite asexual growth assay, and 
quantitative PCR 
RAP (Sigma-Aldrich) was dissolved with dimethyl sulfoxide (DMSO) 
at 4 mg/mL and stored at − 20 ◦C [30]. RAP (4 mg/kg) or an equivalent 
volume of DMSO were intraperitoneally (i.p.) injected into mice infected 
with PyAPH-iKO parasites when the parasitemias reached 20–30%, and 
parasites were collected 24 h later. Schizonts were enriched by density 
gradients using Nycodenz (1.077 g/mL) and incubated in vitro at 15 ◦C 
for 3 h for maturation. Matured schizonts (107) were then intravenously 
(i.v.) injected to BALB/c mice and RAP (4 mg/kg) or DMSO were 
immediately administrated (i.p.). Blood was collected at 3, 12, 24, 36, 
60, and 84 h after parasite inoculation and thin blood smears and gDNA 
were prepared. Blood smears were stained with Giemsa's solution and 
parasitemias were determined. 
gDNA samples were used to evaluate the excision efficiency of the 
aph gene locus by RAP-induced DiCre in the generated parasites using 
quantitative PCR (qPCR) with Power SYBR® Green PCR Master Mix 
(Thermo Fisher Scientific) and specific primer sets; P14 and P15 for the 
unique sequence in PyAPH-iKO parasite and P16 and P17 for the ama1 
gene locus (Table S1) using 7500 Real-Time PCR system (Applied Bio-
systems, Foster City, CA). The excision efficiency of the pypkac gene 
locus by RAP was evaluated as a control [23]. Values for aph were 
normalized to those for ama1. 
To evaluate the effect on parasite egress and erythrocyte invasion, 
the percentage of newly invaded ring stage-infected erythrocytes and 
remaining schizont-infected erythrocytes were examined using blood 
smears obtained at 3 h after inoculation. Two-way ANOVA and a post- 
hoc Tukey's multiple comparison test were performed using GraphPad 
Prism 9 (GraphPad software Inc., San Diego, CA). P values less than 0.05 
was considered statistically significant. 
2.7. Western blotting 
Parasite-infected blood samples were treated with 0.1% saponin to 
lyse the erythrocytes and proteins were extracted with 1% Triton X-100 
in PBS containing a protease inhibitor cocktail (cOmplete™: Sigma- 
Aldrich), separated by SDS-PAGE, then transferred to PVDF mem-
branes. Membranes were immunostained with mouse anti-Myc 
monoclonal antibody (1:1000), mouse anti-Ty monoclonal antibody 
(1:250), or mouse anti-PbHSP70 monoclonal antibody (1:200) at RT for 
1 h, followed by incubation with HRP-conjugated anti-mouse IgG or 
anti-rabbit IgG (1:10000; Promega) at RT for 1 h. Bands were visualized 
using Immobilon Western Chemiluminescent HRP substrate (Millipore) 
and images were taken by a multipurpose charge-coupled-device (CCD) 
camera system (LAS-4000 mini) with Multi Gauge software. The band 
intensities were measured using ImageJ software (v1.53). 
2.8. Antisera production 
Anti-PyMTRAP (PY17X_0513900) was produced by immunization of 
a rabbit with a synthetic peptide DGKGKNNQGSGKD (amino acid po-
sitions 150–162) which was custom synthesized by Cosmo Bio Co. Ltd. 
(Tokyo, Japan). The antiserum was affinity-purified using cellulose 
beads (Cellufine Formyl; JNC corporation, Japan) using the synthetic 
peptide with the same amino acid sequence custom synthesized by 
GenScript (Tokyo, Japan). Briefly, after washing cellulose beads in the 
column, 10 mg of peptide was mixed with 1 mL of beads in 1 mL of 
coupling buffer (50 mM Na2CO3-NaHCO3, pH 8.5) at 4 ◦C on a rotating 
shaker. After adding 10 mg of trimethylamine borane (Tokyo Chemical 
Industry Co. Ltd., Tokyo, Japan), the beads were further shaken at 4 ◦C 
for 8–12 h, washed with a blocking buffer (0.2 M Tris–HCl buffer, pH 
7.0), and mixed with 10 mg of trimethylamine borane. PyMTRAP pep-
tides on the beads were washed with the elution buffer (0.1 M glyci-
ne–HCl, pH 2.5), then with washing buffer (1 M NaCl 1% Triton X-100, 
pH 7.5), and stored at 4 ◦C until use. For capturing peptide-specific 
immunoglobulin from antiserum, 10 mL of rabbit anti-PyMTRAP 
serum was mixed with the PyMTRAP peptide-conjugated beads at 4 ◦C 
for 12 h. After washing, the bound antibodies were eluted with the 
elution buffer to obtain the purified PyMTRAP antibody. 
2.9. Secretion assay 
To detect organelle proteins secreted to the merozoite surface, 
matured schizonts were prepared using Nycodenz and 3 h incubation at 
15 ◦C and were passed through a filter (Φ = 1.2 μm; Sartorius Stedim 
Biotech, Germany) to obtain free erythrocyte-invasive merozoites, 
which were maintained at 15 ◦C throughout the procedure. Merozoites 
were fixed with PFA-GA for 15 min either immediately or after 10 min 
incubation at 37 ◦C, washed with PBS, transferred to the poly-L-lysine 
coated cover slips, and incubated at RT for 30 min. Merozoites were 
permeabilized with 0.1% Triton X-100 in PBS for 10 min at RT if 
required. Merozoites on the cover glasses were then incubated with 3% 
BSA in PBS at RT for 1 h for blocking, incubated with primary antibodies 
at RT for 1 h, washed with PBS, and incubated with secondary anti-
bodies at RT for 30 min. To observe protein secretion by merozoites 
attached to erythrocytes, filtered merozoites were incubated with fresh 
erythrocytes at 37 ◦C for 10 min, then fixed with PFA-GA for 15 min. For 
some experiments, an actin polymerization inhibitor, cytochalasin D 
(final concentration of 1 μM; Sigma-Aldrich) or a same volume of its 
solvent DMSO was added to the matured schizont culture 1 h before 
filtration, then washed twice using incomplete medium (PyCM without 
AlbuMax I) before filtration. Primary antibodies were rabbit anti- 
PyAMA1 (1:250), rabbit anti-MTRAP (1:10), rabbit anti- PyEBL 
(1:250), and mouse anti-Py235 (1:250). The chicken anti-MSP1 anti-
body (1:500) [22] was used to identify merozoites and mouse anti- 
Plasmodium berghei HSP70 monoclonal antibody (obtained from J. Sat-
tabongkot, which cross-reacts with HSP70 orthologs of other Plasmo-
dium spp.) [31] was used to assure the integrity of the parasite 
membrane. The Alexa fluor 488-conjugated goat anti-chicken IgY, Alexa 
fluor 568-conjugated goat anti-mouse IgG, Alexa fluor 647-conjugated 
anti-rabbit IgG, and Alexa fluor 647-conjugated anti-mouse IgG were 
used as secondary antibodies (1:500). IFA images were obtained with a 
confocal microscope (Nikon A1R) under the fixed laser condition. Sum 
intensity and secretion area (%, pixel numbers positive for the signal of 
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target proteins per MSP1 signal positive pixel numbers) were analyzed 
using NIS-elements software (Nikon) and significant differences were 
examined by Mann-Whitney U test. 
2.10. Time-lapse imaging 
Erythrocyte invasive merozoites were purified from RAP- or DMSO- 
pretreated matured schizonts as described [22]. Fresh mouse erythro-
cytes were adjusted to 25,000 erythrocytes/μL with complete culture 
medium for P. yoelii (PyCM, RPMI1640 medium supplemented with 
0.23% sodium bicarbonate, 1% AlbuMax I, 25 mM HEPES, 50 μg/mL 
hypoxanthine, and 10 μg/mL gentamicin), and kept at 37 ◦C. The set-
tings for time-lapse imaging were as described [8]. Briefly, the prepared 
erythrocytes were transferred to μ-Slide VI 0.4 chambers (ibidi, Ger-
many) and kept at RT for 10 min to allow the erythrocytes to settle to the 
bottom of the chamber. Then, purified merozoites were added and the 
chambers were placed on the stage of an inverted microscope (Nikon 
Ti2-E) for video imaging with a CCD camera (ORCA-R2; Hamamatsu 
Photonics, Japan) for 40 min. Merozoites that attached to erythrocytes 
were assessed for 5 min to characterize subsequent invasion steps. The 
two-tailed Fisher's exact test was used for statistical analysis. 
3. Results 
3.1. Expression of APH in P. yoelii 
To evaluate the expression and function of APH in P. yoelii, trans-
genic P. yoelii lines were created whose aph gene locus could be excised 
by RAP treatment. Firstly, the 3′ side of the aph gene locus of P. yoelii 
17XL DiCre parasite was independently modified twice to yield two 
APH-3’loxP parasite clones (Fig. 1A). Two PyAPH-3’loxP clones were 
further independently modified to yield PyAPH-iKO (Fig. 1B). PCR with 
primers P1 and P2 amplified a ~ 2.3-kb band from the parental 17XL 
DiCre parasite, a ~ 5-kb band from PyAPH-3’loxP parasite clone #1 
before 5FC treatment, and a ~ 2.3-kb band from PyAPH-3’loxP parasites 
(uncloned and two clones) after 5FC treatment, confirming the expected 
modification of the target region after each step (Fig. 1C). Subsequent 
PCR amplified a ~ 3-kb band from APH-3’loxP clone #1 and a ~ 2.9-kb 
band from APH-iKO clones with primers P3 and P2; but ~0.9-kb bands 
were only amplified from APH-iKO clones with primers P3 and P4, and 
from the APH-3’loxP clone with primers P3 and P5 (Fig. 1D). These are 
consistent to the sizes expected based upon the transgenic design. 
Southern blot analysis for DNA fragments digested with HpaI and EcoRI 
and detected with the probe 1 revealed a ~ 3.3-kb band for the parental 
17XL DiCre parasite line, a > 6-kb band for PyAPH-3’loxP consistent 
with the insertion of the hDHFR/yFCU expression cassette, an ~3.4-kb 
band for PyAPH-3’loxP clones #1 and #2 after 5FC treatment consistent 
with the removal of the hDHFR/yFCU expression cassette, and an ~3.3- 
kb band for PyAPH-iKO clones #1 and #2 consistent with the replace-
ment of the intron region (Fig. 1E). Southern blot digested with NdeI and 
ScaI and detected with the probe 2 showed an ~7-kb band only for 
PyAPH-3’loxP before 5FC treatment, indicating the absence of the 
hDHFR/yFCU expression cassette in the APH-3’loxP and APH-iKO 
clones (Fig. 1F). The pDC2-Cas9-PyU6-PyAPH-5’loxPi plasmid diges-
ted with ApaI and KpnI was used as a positive control and was positive 
for both probes. 
In T. gondii, conditional knockdown of TgAPH resulted in the loss of 
MIC2 and AMA1 secretion. Thus, to characterize the Plasmodium MIC2 
homolog, MTRAP, we generated a transgenic P. yoelii line in which the 
MTRAP C-terminal end was fused with a Ty-tag (Fig. S1A and B). 
Western blot analysis revealed that the signals detected with anti-Ty 
antibody and the anti-PyMTRAP antibody generated for this study 
showed similar sized bands (Fig. S1C and D) as well as completely 
overlapped IFA signals (Fig. S1F), thus validating that the anti-MTRAP 
antibody detected native PyMTRAP protein. 
To evaluate the P. yoelii APH (PyAPH) cellular localization, IFA was 
performed at the schizont stage (Fig. 2A) using PyAPH-iKO parasites 
with anti-Myc antibody and known marker proteins including AMA1 
(microneme), MTRAP (microneme), EBL (dense granule-like organelle 
in Py17XL), RON5 (rhoptry neck), Py235 (rhoptry), and HSP70 
(cytosol). APH-Myc signals were largely overlapped with MTRAP-Ty 
signals with the highest Pearson's correlation coefficient value (0.76 
± 0.09), but less overlapped with AMA1 signals (0.60 ± 0.10). IFA of 
P. yoelii schizonts expressing MTRAP-Ty dual-stained with anti-Ty and 
anti-AMA1 antibodies also showed that these two signals did not have 
significant overlap (Fig. S1E). This result suggests that PyAPH is only 
associated with micronemes containing MTRAP, but not AMA1- 
containing micronemes or only a part of AMA1-containing micro-
nemes associate with APH. 
3.2. APH protein expression was reduced to ~11% 24 h after RAP 
treatment 
The effect of RAP administration to PyAPH-iKO parasites on the APH 
expression level was evaluated using synchronized parasites. Mature 
schizonts obtained by Nycodenz-enrichment and in vitro incubation at 
15 ◦C were inoculated into mice and RAP or DMSO were immediately 
administrated (i.p.). Western blot analysis revealed that RAP-treated 
clones expressed a low amount of Myc-tagged APH compared to the 
Fig. 2. Indirect immunofluorescence assay for P. yoelii APH. 
IFA images of the schizont stage of PyAPH-iKO parasites. Fluorescent signals 
with anti-Myc antibody (green, PyAPH) were merged with DAPI nucleus signals 
(blue), and marker protein signals (red: AMA1, microneme; EBL, dense granule- 
like organelle; RON5, rhoptry neck; Py235, rhoptry; MTRAP-ty, microneme; 
and HSP70, cytoplasm). Differential interference contrast (DIC) images are also 
shown. Scale bars, 2 μm. Average and standard deviation (SD) of the Pearson's 
correlation coefficient values were from 10 images. (For interpretation of the 
references to colour in this figure legend, the reader is referred to the web 
version of this article.) 
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DMSO-treated controls 24 h later (Fig. 3A and S2A arrow). When the 
APH band intensities were normalized by the intensities of HSP70 
bands, the amounts of APH in RAP-treated clones were 12% and 11% for 
clones #1 and #2, respectively, compared to the DMSO-treated controls 
(Fig. 3B and S2B). An extra band at ~21 kDa was detected in the DMSO- 
treated parasites with anti-Myc antibody which was not seen in the 
parasites before DMSO administration (Fig. 3A and S2A arrowhead). 
This ~21-kDa band was repeatedly detected from the independently 
prepared parasite samples, suggesting that PyAPH expressed in PyAPH- 
iKO parasite was somehow processed by DMSO administration. None-
theless, these data indicated that APH was dramatically reduced in 
PyAPH-iKO parasites by RAP administration and validated the usage of 
these parasite clones for functional analysis. 
Fig. 3. APH expression, in vivo asexual 
growth, and erythrocyte invasion by RAP- 
treated PyAPH-iKO blood stage parasites. 
(A) Top, Western blot for Myc-tagged PyAPH 
with anti-Myc antibody. Bands matching the 
theoretical molecular weight of Py APH-Myc 
(~32 kDa) are indicated with an arrow. 
Extra bands at ~21 kDa are indicated with 
an arrowhead. Bottom, P. yoelii HSP70 bands 
are detected and used as loading controls. (B) 
The intensities of the bands on the Western 
blots were quantified and the values of ~32- 
kDa PyAPH bands were normalized by those 
of HSP70 bands. Obtained values of DMSO- 
treated control parasites were set to 100%. 
(C) Parasitemias in mice were monitored for 
PyAPH-iKO clones #1 and #2, and a 
PyPKAc-iKO clone (n = 5 for each) at 3, 12, 
24, 36, 60, and 84 h after inoculation of 
matured schizonts pre-treated with RAP- or 
DMSO followed by immediate administra-
tion of RAP or DMSO, respectively. Para-
sitemias of the Py17XL-DiCre parasites were 
also monitored as controls without drug 
administration. Asterisks indicate that the 
parasitemias of RAP-treated PyAPH-iKO 
clones were significantly lower than those of 
DMSO-treated PyAPH-iKO groups (p <
0.0001) by the post-hoc Tukey's multiple 
comparison test following two-way ANOVA. 
(D) Relative values of the parasite DNA with 
the excised aph or pkac gene locus to all 
parasite DNA obtained from samples are 
shown in panel C. (E) Results of the assess-
ment of in vivo egress and erythrocyte inva-
sion for PyAPH-iKO clones #1 and #2, and a 
PyPKAc-iKO clone (n = 5 for each). Asterisks 
indicate significant differences (p < 0.0001).   
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3.3. Deletion of APH severely affected the P. yoelii asexual growth and 
erythrocyte invasion, but was not lethal 
Next, the effect of the excision of the aph gene locus on parasite 
asexual growth was examined. PyAPH-iKO clones treated with RAP or 
DMSO for 24 h were synchronized, and mature schizonts were injected 
into fresh BALB/c mice with RAP or DMSO, then parasitemias were 
monitored for 84 h without additional RAP or DMSO administration. In 
addition to a parental 17XL-DiCre parasite, a PKAc-iKO parasite clone, 
in which the pkac gene locus coding for an essential protein for the 
erythrocyte invasion can be excised with RAP, was also monitored as a 
control. With DMSO, two APH-iKO clones and the PKAc-iKO clone 
showed parasitemias of >0.5% at 3 h and grew similar to the parental 
DiCre parasite (Fig. 3C). When RAP was administered, the parasitemias 
of theAPH-iKO clones #1 and #2 were 0.02 ± 0.01% and 0.04 ± 0.03%, 
respectively, much lower than the parasitemia of the control DMSO- 
treated groups, but higher than that of the PKAc-iKO clone (0.004 ±
0.001%), suggesting that APH-iKO had important, but not essential roles 
during egress or the cell invasion process. At 12 h, the parasitemias of 
RAP-treated APH-iKO clones and the PKAc-clone were not reduced, 
suggesting non-essential roles of these proteins during intraerythrocytic 
growth up to this time point. At 24 h when synchronized parasites were 
matured and were invading new erythrocytes, the parasitemia of the 
RAP-treated PKAc-iKO clone was further reduced to 0.001 ± 0.000%, 
whereas the parasitemias of RAP-treated APH-iKO clones #1 and #2 
were not reduced (0.05 ± 0.02% and 0.07 ± 0.01%, respectively), but 
also not increased like for the DMSO-treated groups; again suggesting 
roles, albeit non-essential, of APH during egress or cell invasion. 
To exclude a potential low excision efficacy of the aph gene locus in 
APH-iKO clones during this experiment, a proportion of the parasites in 
which the target gene locus was excised were monitored (Fig. 3D). We 
found that the aph gene locus was excised in ~95% of the RAP-treated 
parasites from 0 to 36 h. Together these data indicate that even 
though the aph gene locus was not intact past 24 h, some parasites were 
able to egress and invade new erythrocytes. 
At 36 h, the parasitemia of the RAP-treated PKAc-iKO clone was not 
reduced further and increased at 60 and 84 h, which is consistent to the 
increased proportion of the parasites in which the target gene locus was 
intact; suggesting that the RAP concentration in the mouse blood 
became too low to excise the target gene locus. 
To further evaluate the roles of APH in P. yoelii on egress and cell 
invasion, schizont-infected erythrocytes and erythrocytes with newly 
invaded ring stage parasites were separately counted from the smears 
prepared 3 h after inoculation. The effects on the PKAc-iKO parasites 
were consistent to a report showing that the ring stage parasitemia of the 
RAP-treated group (0.004 ± 0.001%) was significantly lower than that 
of the DMSO-treated group (0.54 ± 0.16%, p < 0.0001) and no differ-
ence was detected for the schizontemias between the two groups 
(Fig. 3E) [23], validating that this assay was properly conducted. The 
ring stage parasitemias of the RAP-treated PyAPH-iKO clones #1 and #2 
were 0.02 ± 0.01% and 0.04 ± 0.03%, respectively, significantly lower 
than those of DMSO-treated groups (0.57 ± 0.15% and 0.52 ± 0.11%, 
respectively) (Fig. 3E). The schizontemias of the RAP-treated PyAPH- 
iKO clones #1 and #2 were 0.01 ± 0.00% and 0.01 ± 0.01%, respec-
tively, not significantly different from those of the DMSO-treated groups 
(0.02 ± 0.01% and 0.03 ± 0.04%, respectively) (Fig. 3E); suggesting 
that APH plays a role during erythrocyte invasion but is not observably 
involved in the egress process of P. yoelii. 
3.4. APH is required for secretion of MTRAP and AMA1, but not EBL and 
Py235 
To compare with the observations for T. gondii, in which MIC2 and 
AMA1 secretion was inhibited when TgAPH was knocked down, we 
examined the consequence of aph gene locus excision in P. yoelii on the 
secretion of invasion-related molecules; namely, MTRAP (MIC2 
homolog), AMA1, EBL, and Py235. By IFA, we found trace or absent 
signals of MTRAP and AMA1 on the surface of PyAPH-iKO merozoites 
prepared from RAP-treated matured schizonts even after 10 min incu-
bation at 37 ◦C, whereas both signals were clearly visible on merozoites 
treated with DMSO (Fig. 4A and C). HSP70 was detected from the Triton 
X-100-treated merozoites, but not from the untreated merozoites, indi-
cating that the plasma membranes of the test samples were intact. 
Quantitative assessment revealed that both the sum intensities and 
signal positive areas for AMA1 and MTRAP on the merozoite surface 
were significantly lower than those of DMSO-treated parasites at 0 min 
and after 10 min incubation (Fig. 4B and D, p < 0.0001). In contrast to 
AMA1 and MTRAP, no obvious differences were observed for the 
secretion of EBL and Py235 between RAP- and DMSO-treated merozo-
ites, indicating that the excision of the aph gene locus had no effect on 
the secretion of these proteins (Fig. 4E–H). 
3.5. Deletion of APH impaired P. yoelii internalization into erythrocytes, 
but had no effect on tight junction formation 
Time-lapse image analysis was performed to describe the invasion 
steps affected by the absence of APH in P. yoelii. Merozoites pretreated 
with RAP or DMSO were incubated with fresh erythrocytes and 
approximately 50–70 merozoites that attached to the erythrocytes were 
evaluated for 5 min for (i) erythrocyte deformation, (ii) detachment 
from the erythrocyte, (iii) parasite internalization into the erythrocyte, 
and (iv) echinocytosis. Examples are presented for successful invasion 
by the DMSO-treated merozoite (Fig. 5A and video 1) and unsuccessful 
invasion by the RAP-treated merozoite (Fig. 5A and video 2). We found 
no significant difference for the proportion of merozoites that were able 
to deform erythrocytes between RAP-treated (84% and 79% for clones 
#1 and #2) and DMSO-treated parasites (88% and 74%, respectively) 
(Fig. 5B). Erythrocyte deformation is linked to merozoite gliding 
motility [5], and is likely mediated by TRAP family proteins. Thus, this 
result was unexpected because the secretion of MTRAP, a TRAP family 
member expressed at the merozoite stage, was severely impaired in RAP- 
treated APH-iKO parasites. 
We observed that 60% (25/42) and 43% (21/36) of DMSO-treated 
PyAPH-iKO clones #1 and #2 merozoites that deformed erythrocytes 
showed echinocytosis, whereas the ratios of RAP-treated merozoites 
were significantly lower at 8% (4/52) and 7% (3/41), respectively 
(Fig. 5C, p < 0.0001). These data indicated that the excision of the aph 
gene locus had a strong impact on merozoite internalization into the 
erythrocyte and the subsequent echinocytosis event, but still 7– 8% were 
able to complete the invasion process, consistent with the observation 
that RAP-treated parasites were able to slowly proliferate (Fig. 3C). The 
ratio of the merozoites not detached from the erythrocyte per those 
attached but not internalized to the erythrocyte were 81% (39/48) and 
82% (31/38) for RAP-treated APH-iKO clones #1 and #2 merozoites, 
significantly higher than the 53% (9/17) and 40% (6/15) observed for 
DMSO-treated merozoites, respectively (Fig. 5D, p < 0.05). This obser-
vation that un-internalized merozoites were kept attached to the 
erythrocyte membrane, indicated that the tight junction was established 
between the merozoite and the erythrocyte even following APH 
deletion. 
3.6. MTRAP is APH-independently secreted to the surface of merozoites 
that attached to the erythrocyte 
To explore the possible reasons why APH-deficient merozoites were 
able to deform erythrocyte membranes, we firstly reconfirmed whether 
the observed erythrocyte deformation by P. yoelii was linked to acto-
myosin motor activity. We performed time-lapse image analysis during 
the erythrocyte invasion using a wild type 17XL parasite line treated 
with cytochalasin D (CytD), an actin polymerization inhibitor, to inhibit 
the merozoite motor activities (Fig. 6A and video 2) or control DMSO 
(Fig. 6A and video 1). After attaching to erythrocytes, erythrocyte 
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deformation events by CytD-treated merozoites (Fig. 6B; 9% (3/35)) 
were significantly lower than those by DMSO-treated merozoites 
(Fig. 6B; 68% (26/38)) and none of the CytD-treated merozoites were 
able to complete the invasion process. These data confirmed that 
merozoite actomyosin motor activities were indeed linked to the 
erythrocyte deformation by P. yoelii merozoites. 
Secondly, we examined whether micronemes could discharge when 
merozoites were attached to the erythrocyte, and thereby are able to 
start to glide and deform erythrocytes. RAP- or DMSO-treated merozo-
ites were incubated with fresh mouse erythrocytes at 37 ◦C for 10 min, 
then labeled with anti-AMA1 or anti-MTRAP antibodies. Because DMSO- 
treated merozoites are quickly internalized, the chance to capture 
merozoite images attached on the erythrocyte was low. Thus, we 
decided to assess microneme secretion in the presence of CytD. Under 
both the absence or presence of CytD, MTRAP, but not AMA1, was 
detectable on the surface of RAP-treated merozoites (Fig. 7A and C). 
Quantitative assessment revealed that both the sum intensity and signal 
positive areas for AMA1 on the RAP-treated merozoites were signifi-
cantly lower than those of DMSO-treated parasites (Fig. 7B, p < 0.001). 
Although the sum intensities of MTRAP signals on the RAP-treated 
merozoites were significantly lower than those of DMSO-treated mero-
zoites (p < 0.001), no differences were detected on the signal positive 
areas between RAP- and DMSO-treated merozoites (Fig. 7D); indicating 
that lower amounts of MTRAP, but not AMA1, were secreted and 
distributed on the surface of merozoites that attached to erythrocytes. 
Because protein secretion was evaluated 10 min after merozoite incu-
bation at 37 ◦C for both free merozoites (Fig. 4) and merozoites with 
erythrocytes (Fig. 7), we interpreted that the contact of merozoites to the 
erythrocytes induced the secretion of MTRAP. 
4. Discussion 
In this study we examined the function of P. yoelii APH 
(PY17X_0716800), whose ortholog in T. gondii has a role in parasite 
egress and cell invasion and is essential for survival [20]. Unlike 
T. gondii, we found that P. yoelii APH is primarily required for erythro-
cyte invasion, but not for egress during the blood stage. Egress of 
T. gondii is dependent on the disruption of the parasitophorous vacuole 
membrane by a microneme protein, Toxoplasma perforin-like protein 1 
(TgPLP1) [32]; thus it is reasonable that knockdown of TgAPH reduced 
the egress of this parasite. In contrast, egress of malaria parasites is 
initiated by the secretion of the subtilisin-like serine protease PfSUB1 
from exonemes, an organelle distinct from micronemes [21]. Thus, our 
observation that loss of APH does not impact parasite egress can be 
explained by no involvement of APH in exoneme discharge in malaria 
parasites. 
Fig. 4. Protein secretion by RAP-treated PyAPH-iKO merozoites. 
Purified invasive merozoites of the PyAPH-iKO parasite pretreated with RAP or DMSO were labeled with a panel of antibodies against AMA1 (A), MTRAP (C), EBL 
(E), or Py235 (G) at 0 and 10 min after incubation at 37 ◦C with or without permeabilization with Triton X-100 (TritonX (+) or (− )). Target proteins AMA1, MTRAP, 
EBL, and Py235 are colored in red. MSP1 (green) and HSP70 (yellow) were counterstained. Scale bar, 2 μm. Sum intensity (top) and secretion area (bottom) of signals 
for AMA1 (B), MTRAP (D), EBL (F), or Py235 (G) of 15 merozoites were obtained by NIS-elements software and significant difference was examined by Mann- 
Whitney U test. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.) 
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This study demonstrated that IFA signals of APH in P. yoelii mero-
zoites were highly overlapped with PyMTRAP signals, but less over-
lapped with PyAMA1 signals. Nevertheless, secretion of both PyMTRAP 
and PyAMA1 were impaired by the excision of the aph gene locus. These 
suggest that interaction of PyAPH and PA is directly responsible for 
PyMTRAP secretion, but the secretion of PyAMA1 may be indirectly 
triggered. This is consistent to the observation of erythrocyte contact- 
dependent secretion of PyMTRAP, but not PyAMA1 (Fig. 7). However, 
it is unclear if secretion of the TRAP family protein is prerequisite of 
AMA1 secretion or not, which needs future investigation. In addition, we 
emphasize that our observation that deletion of APH in P. yoelii had a 
significant impact on the secretion of PyMTRAP and PyAMA1, but not 
EBL secretion; which complements a report by Ebrahimzadeh et al. 
(2019), who showed that the disruption of another pleckstrin homology 
domain-containing protein PH2 in P. falciparum affected EBL secretion, 
but not PfAMA1 secretion. Thus, two different pleckstrin homology 
domain-containing proteins, PfAPH and PfPH2, appear to regulate 
exocytosis of different sets of microneme vesicles in a mutually exclusive 
manner. 
Our unexpected finding that P. yoelii without APH was able to deform 
Fig. 5. Time-lapse image analysis of RAP-treated PyAPH-iKO parasites during erythrocyte invasion. 
(A) Images of different steps during erythrocyte invasion (initial attachment, erythrocyte deformation, internalization, and echinocytosis) by DMSO- or RAP-treated 
PyAPH-iKO parasites captured from representative time-lapse videos (Videos 1 and 2, respectively). For the RAP-treated PyAPH-iKO parasite (clone #1), a merozoite 
is shown that was not internalized yet not detached from the erythrocyte 5 min after the initial attachment. Arrows and an arrowhead indicate merozoites and an 
erythrocyte exhibiting echinocytosis, respectively. (B) Percentage of the deformation event per the initial attachment event. (C) Percentage of the echinocytosis event 
per the deformation event. (D) Percentage of the merozoites detached or not detached from the erythrocyte per the merozoites not internalized into the erythrocyte. 
The observed numbers of each event are shown below each graph. Significant difference was examined by two-tailed Fisher's exact test. n.s. indicates not significant 
(p ≥ 0.05). 
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erythrocytes may be explained by the erythrocyte contact-dependent 
secretion of PyMTRAP; however, the involvement of PyMTRAP in 
merozoite gliding motility is not yet determined. Because MTRAP 
orthologs are dispensable in P. falciparum and P. berghei during asexual 
blood stage development [33], other proteins may be responsible for 
erythrocyte deformation, such as another TRAP member and merozoite 
microneme protein, Plasmodium thrombospondin-related apical mero-
zoite protein (PTRAMP) [34]. 
Although we did not detect PyAMA1 secretion from the RAP-treated 
APH-iKO clone even after the merozoite contact with erythrocytes, 7– 
8% of merozoites were able to invade. Two possibilities may be raised; 
one is that some merozoites utilize a low amount of PyAMA1 that could 
be secreted after PyMTRAP secretion, and the other is that some mer-
ozoites may be able to invade without PyAMA1. The latter case is sup-
ported by piggyBac transposon insertional mutagenesis analysis of 
P. falciparum; which revealed that the mutagenesis index score (MIS) of 
PfAMA1 was 0.78 (on a scale of 0–1, when a lower MIS indicates a lower 
possibility of essentiality), suggesting that some merozoites were able to 
invade without PfAMA1 [35,36]. Relatively stable parasitemia of the 
RAP-treated PyAPH-iKO clones compared to the rapid reduction of 
parasitemia of the RAP-treated PyPKA-iKO clone from 3 to 24 h (Fig. 3C) 
are consistent to the results of this mutagenesis analysis; specifically, the 
MIS of PfAPH was 0.68 and that of PfPKAc was 0.2. 
In conclusion, we generated transgenic parasite lines for which 
PyAPH can be conditionally knocked out using the DiCre conditional 
recombinase system. We demonstrated that PyAPH has an important 
role for the secretion of PyMTRAP and PyAMA1, thus excision of the aph 
gene locus severely impaired erythrocyte invasion and parasite asexual 
growth. We showed that PyAPH colocalized with PyMTRAP, but not 
with PyAMA1 and proposed that different direct signals exist to trigger 
the secretion of PyMTRAP versus PyAMA1. We also proposed that 
erythrocyte-contact may trigger PyMTRAP secretion. Further investi-
gation of these new findings will provide a better understanding of the 
molecular mechanism of erythrocyte invasion by malaria parasites and 
may lead to the discovery of novel drug targets. 
Supplementary data to this article can be found online at https://doi. 
Fig. 6. Time-lapse image analysis of cytochalasin D-treated wild type 17XL parasites during erythrocyte invasion. 
(A) Images of different steps during the erythrocyte invasion (initial attachment, erythrocyte deformation, internalization, and echinocytosis) of DMSO- or cyto-
chalasin D (CytD)-treated 17XL wild type parasites captured from representative time-lapse videos (Videos 3 and 4, respectively). For the CytD-treated parasite, a 
merozoite is shown that was not internalized yet not detached from the erythrocyte 5 min after the initial attachment. Arrows and an arrowhead indicate merozoites 
and an erythrocyte exhibiting echinocytosis, respectively. (B) Percentage of the deformation event per the initial attachment event. (C) Percentage of the merozoites 
detached or not detached from the erythrocyte per the merozoites not internalized into the erythrocyte. The observed numbers of each event are shown below the 
graphs. Significant difference was examined by two-tailed Fisher's exact test. 
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Fig. 7. Protein secretion by RAP-treated PyAPH-iKO merozoites that attached to the erythrocytes. 
Purified invasive merozoites of the PyAPH-iKO parasite pretreated with RAP or DMSO were incubated with erythrocytes for 10 min at 37 ◦C with or without 
permeabilization with Triton X-100 (TritonX (+) or (− )), then labeled with a panel of antibodies against AMA1 (A) or MTRAP (C). Target proteins AMA1 and MTRAP 
are colored in red. MSP1 (green) and HSP70 (yellow) were counterstained. To observe more merozoites trapped on erythrocytes, parasites were also treated with 
cytochalasin D (CytD). Scale bar, 2 μm. Sum intensity (top) and secretion area (bottom) of signals for AMA1 (B) or MTRAP (D) of 5–10 merozoites were obtained by 
NIS-elements software and significant difference was examined by Mann-Whitney U test. (For interpretation of the references to colour in this figure legend, the 
reader is referred to the web version of this article.) 
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